Ashton Thomas Private Wealth LLC decreased its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 51.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,270 shares of the technology company's stock after selling 38,814 shares during the quarter. Ashton Thomas Private Wealth LLC's holdings in Amdocs were worth $3,020,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of the stock. Pzena Investment Management LLC boosted its stake in Amdocs by 0.6% in the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company's stock valued at $540,976,000 after buying an additional 42,184 shares in the last quarter. LSV Asset Management boosted its stake in Amdocs by 7.6% in the 3rd quarter. LSV Asset Management now owns 3,648,703 shares of the technology company's stock valued at $299,376,000 after buying an additional 257,193 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Amdocs by 1.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company's stock valued at $253,786,000 after buying an additional 54,676 shares in the last quarter. Wellington Management Group LLP boosted its stake in Amdocs by 3.0% in the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company's stock valued at $258,583,000 after buying an additional 91,900 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Amdocs by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company's stock valued at $251,602,000 after buying an additional 9,207 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the company. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a research report on Saturday, April 18th. Weiss Ratings reiterated a "hold (c)" rating on shares of Amdocs in a research report on Tuesday, January 27th. Stifel Nicolaus cut their price objective on Amdocs from $97.00 to $88.00 and set a "buy" rating for the company in a research report on Wednesday, February 4th. Finally, Barclays cut their price objective on Amdocs from $111.00 to $92.00 and set an "overweight" rating for the company in a research report on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $92.33.
View Our Latest Report on Amdocs
Amdocs Trading Down 0.7%
NASDAQ DOX opened at $64.27 on Wednesday. The stock has a 50-day simple moving average of $66.50 and a 200 day simple moving average of $75.03. The company has a market capitalization of $6.94 billion, a PE ratio of 12.43, a P/E/G ratio of 1.14 and a beta of 0.46. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 12 month low of $62.75 and a 12 month high of $95.41.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.75 by $0.06. The business had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The firm's revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Research analysts forecast that Amdocs Limited will post 6.64 EPS for the current year.
Amdocs Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Tuesday, March 31st were issued a $0.569 dividend. This is a boost from Amdocs's previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date was Tuesday, March 31st. Amdocs's dividend payout ratio is currently 44.10%.
Amdocs Profile
(
Free Report)
Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.
Further Reading
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.